|
|
|
American Chinese Pharmaceutical Association
|
|
|
|
|
|
|
|
|
|
|
|
The Officers and Executives: General Secretary - Bing V. Li, Ph. D.
Dr. Li is a Lead Pharmacologist and Team Leader in the Division of Bioequivalence, Office of Generic Drugs, Center of Drug Evaluation and Research, U.S. Food and Drug Administration (FDA). Her current responsibility is to review drug products submitted in Abbreviated New Drug Applications (ANDAs), to determine the adequacy of the data from bioequivalence studies based on study design, analytical methodology, and statistical analysis. Prior to joining FDA in 2004, she was a research investigator at Bristol-Myer-Squibb where her responsibilities included formulation identification, development and optimization for oral solid dosage form formulations. She received her PhD in Pharmaceutical Sciences from University of Wisconsin at Madison in 2001, and a bachelor degree in Medical Chemistry in 1990 in Beijing Medical University, China.
|
|
|
| |
© Copyright
2010 American Chinese Pharmaceutical Association. All rights reserved.
|
ACPA, P.O. Box 10193 | Rockville , MD 20849-0193 , USA
Email:info@acpa-rx.org
|
|
|
|
|
|
|